REGISTERED
on 21 Nov 2023
Last Applicant/ Owned by
301 - 980 George Street
Vancouver
CA
V6Z0H9
Serial Number
90793194 filed on 24th Jun 2021
Registration Number
7225401 registered on 21st Nov 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
INCISIVE GENETICS
Scientific and medical research Reagents, namely, lipid nanoparticles, for scientific and research use Pharmaceutical drug delivery system, namely, lipid nanoparticles, for medicinal use; Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for genetic medicines
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and medical research
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Class [005]
Pharmaceutical Products
Pharmaceutical drug delivery system, namely, lipid nanoparticles, for medicinal use; Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for genetic medicines
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Class [001]
Chemical Products
Reagents, namely, lipid nanoparticles, for scientific and research use
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Mark Details
Serial Number
No 90793194
Mark Type
No Service Mark
Attorney Docket Number
No 2957415.101
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.29 -
Helixes
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
| 21st Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 14th Oct 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 13th Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 03rd Jul 2023 | SU - FINAL REFUSAL - WRITTEN |
| 03rd Jul 2023 | FINAL REFUSAL E-MAILED |
| 03rd Jul 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 23rd Jun 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 23rd Jun 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 23rd Jun 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |